Impact of loss to follow-up on survival estimation for cystic fibrosis

被引:3
|
作者
Ostrenga, Joshua S. [1 ,3 ]
Brown, A. Whitney [1 ]
Todd, Jonathan, V [1 ]
Elbert, Alexander [1 ]
Fink, Aliza K. [2 ]
Faro, Albert [1 ]
Marshall, Bruce C. [1 ]
Cromwell, Elizabeth A. [1 ]
机构
[1] Cyst Fibrosis Fdn, Clin Affairs, Bethesda, MD USA
[2] Natl Org Rare Disorders, Res Programs, Washington, DC USA
[3] Cyst Fibrosis Fdn, Bethesda, MD 20814 USA
关键词
Cystic fibrosis; Registry data; Survival analysis; Loss to follow-up; DIAGNOSIS; GUIDELINES; ADULTS;
D O I
10.1016/j.annepidem.2023.07.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Deaths among those lost to follow-up (LTFU) in the Cystic Fibrosis Foundation Patient Registry (CFFPR) are critically important to the epidemiology of cystic fibrosis (CF). Unreported deaths could impact estimates of survival if LTFU is associated with disease trajectory.Methods: We characterized the LTFU population (1986-2017) from the CFFPR and identified deaths via linkage with the National Death Index (NDI). Median predicted survival age and conditional survival were estimated with and without additional deaths and person-time from the NDI.Results: Of the 10,582 individuals LTFU in the CFFPR, 2,460 (23.2%) matched to an NDI death record. Individuals who died after LTFU with a CF diagnosis were 43% female, 91% White/non-Hispanic, 59% had advanced CF lung disease based on last CFFPR recorded forced expiratory volume in one second (FEV1) %predicted < 40 and 18% were post-lung transplant. Median predicted survival age during the most recent period available, 2013-2017, increased from 44.3 years (95% CI: 43.2, 45.7) to 45.8 years (95% CI 44.5, 47.1) with the inclusion of NDI data.Conclusions: Inclusion of deaths and additional person-time among those LTFU changed the point estimate of median predicted survival for most time periods and increased the point estimate from 2009 onwards.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:98 / +
页数:11
相关论文
共 50 条
  • [1] LOSS TO FOLLOW-UP WEIGHTED ESTIMATION METHOD FOR SURVIVAL ANALYSIS
    Krishna, K. M. Jagathnath
    Hari, Akash
    Traison, T.
    George, Preethi Sara
    Mathew, Aleyamma
    ADVANCES AND APPLICATIONS IN STATISTICS, 2023, 85 : 55 - 78
  • [2] SURVIVAL ANALYSIS OF CYSTIC FIBROSIS AFTER NEONATAL SCREENING: 40 YEARS OF FOLLOW-UP
    Tridello, G.
    Iansa, P.
    Castellani, C.
    Assael, B. M.
    PEDIATRIC PULMONOLOGY, 2011, : 370 - 370
  • [3] Gynecological management and follow-up in women with cystic fibrosis
    Rousset-Jablonski, C.
    Reynaud, Q.
    Nove-Josserand, R.
    Durupt, S.
    Durieu, I.
    REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (06) : 592 - 603
  • [4] Impact of practice recommendations on patient follow-up and cystic fibrosis centres' activity in France
    Decullier, Evelyne
    Touzet, Sandrine
    Bourdy, Stephanie
    Termoz, Anne
    Bellon, Gabriel
    Pin, Isabelle
    Cracowski, Claire
    Colin, Cyrille
    Durieu, Isabelle
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (01) : 70 - 75
  • [5] IMPACT OF PAIN ON CLINICAL OUTCOMES IN ADULTS WITH CYSTIC FIBROSIS: NINE YEARS OF FOLLOW-UP
    Allgood, S. J.
    Dezube, R.
    Rivers, E.
    Lechtzin, N.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S394 - S394
  • [6] Follow-up of lung function in infants and children with cystic fibrosis
    Kraemer, R.
    Cripe-Mamie, C.
    Tennhoff, W.
    Buehlmann, U.
    Gallati, S.
    SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 5S - 5S
  • [7] Mild cystic fibrosis: Genetics - extending follow-up is necessary
    Gaillard, D.
    Clavel, C.
    Bessaci-Kabouya, K.
    Abely, M.
    ARCHIVES DE PEDIATRIE, 2009, 16 (04): : 387 - 390
  • [8] VECTORCARDIOGRAM IN CYSTIC FIBROSIS - A 5-YEAR FOLLOW-UP
    KRAUSE, D
    LIEBMAN, J
    DOWNS, TD
    DOERSHUK, C
    MATTHEWS, L
    DISEASES OF THE CHEST, 1969, 56 (03): : 256 - &
  • [9] DETECTION AND FOLLOW-UP OF LIVER FIBROSIS IN CYSTIC FIBROSIS: A ROLE FOR DIAGNOSTIC LIVER BIOPSY AND SERUM MARKERS IN THE EVALUATION OF AND FOLLOW UP OF CYSTIC FIBROSIS LIVER DISEASE
    Walsh, Meagan J.
    Lewindon, Peter J.
    Shepherd, Ross W.
    Pereira, Tamara N.
    Greer, Ristan M.
    Bell, Scott
    Ramm, Grant A.
    HEPATOLOGY, 2009, 50 (04) : 758A - 758A
  • [10] Improving cystic fibrosis survival as a result of management in a specialized Center with 10-year follow-up
    Lentini N, Eduardo
    Lopez-Millan, Adriana
    Lores L, Ana Maria
    Pesciullesi B, Maria Rosa
    Ituarte R, Leonor Maria
    Viera C, Teresa Beatriz
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2014, 85 (03): : 281 - 287